Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.

Weis CA, Aban IB, Cutter G, Kaminski HJ, Scharff C, Grießmann BW, Deligianni M, Kayser K, Wolfe GI, Ströbel P, Marx A.

PLoS One. 2018 Jun 13;13(6):e0197435. doi: 10.1371/journal.pone.0197435. eCollection 2018.

2.

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Gwathmey KG, Sadjadi R, Horton WB, Conaway MR, Barnett-Tapia C, Bril V, Russell JW, Shaibani A, Mauermann ML, Hehir MK, Kolb N, Guptill J, Hobson-Webb L, Gable K, Raja S, Silvestri N, Wolfe GI, Smith AG, Malik R, Traub R, Joshi A, Elliott MP, Jones S, Burns TM.

Neurology. 2018 Jun 5;90(23):e2034-e2041. doi: 10.1212/WNL.0000000000005643. Epub 2018 May 4.

PMID:
29728528
3.

Developing treatment guidelines for myasthenia gravis.

Sanders DB, Wolfe GI, Narayanaswami P; MGFA Task Force on MG Treatment Guidance.

Ann N Y Acad Sci. 2018 Jan;1412(1):95-101. doi: 10.1111/nyas.13537. Review.

PMID:
29381223
4.

Learning from the past: reflections on recently completed myasthenia gravis trials.

Benatar M, Howard JF Jr, Barohn R, Wolfe GI, Cutter G.

Ann N Y Acad Sci. 2018 Jan;1412(1):5-13. doi: 10.1111/nyas.13501. Epub 2017 Oct 24.

PMID:
29064567
5.

Start high, then go low: An effective strategy in the treatment of myasthenia gravis.

Silvestri NJ, Wolfe GI.

Muscle Nerve. 2017 Jun;55(6):773-774. doi: 10.1002/mus.25654. Epub 2017 Apr 15. No abstract available.

PMID:
28345201
6.

What's in the Literature?

Lacomis D, Silvestri NJ, Fine EJ, Wolfe GI.

J Clin Neuromuscul Dis. 2017 Mar;18(3):165-175. doi: 10.1097/CND.0000000000000168.

PMID:
28221312
7.

Randomized trial of thymectomy in myasthenia gravis.

Wolfe GI, Kaminski HJ, Sonnett JR, Aban IB, Kuo HC, Cutter GR.

J Thorac Dis. 2016 Dec;8(12):E1782-E1783. doi: 10.21037/jtd.2016.12.80. No abstract available.

8.

Author response: International consensus guidance for management of myasthenia gravis: Executive summary.

Sanders DB, Wolfe GI, Narayanaswami P.

Neurology. 2017 Jan 31;88(5):505-506. doi: 10.1212/WNL.0000000000003570. No abstract available.

PMID:
28138082
9.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Wolfe GI, Kaminski HJ, Cutter GR.

N Engl J Med. 2016 Nov 17;375(20):2006-2007. doi: 10.1056/NEJMc1611704. No abstract available.

PMID:
27959593
10.

Rituximab in Treatment-Refractory Myasthenia Gravis.

Silvestri NJ, Wolfe GI.

JAMA Neurol. 2017 Jan 1;74(1):21-23. doi: 10.1001/jamaneurol.2016.4367. No abstract available.

PMID:
27892981
11.

What's in the Literature?

Silvestri NJ, Wolfe GI, Lacomis D.

J Clin Neuromuscul Dis. 2016 Dec;18(2):108-117.

PMID:
27861229
12.

Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis.

Salins S, Teter B, Kavak K, Wolfe GI, Silvestri NJ.

J Clin Neuromuscul Dis. 2016 Dec;18(2):61-66.

PMID:
27861217
13.

What's in the Literature?

Silvestri NJ, Wolfe GI, Lacomis D, Bromberg MB.

J Clin Neuromuscul Dis. 2016 Sep;18(1):47-59. doi: 10.1097/CND.0000000000000139.

PMID:
27552392
14.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group.

N Engl J Med. 2016 Aug 11;375(6):511-22. doi: 10.1056/NEJMoa1602489. Erratum in: N Engl J Med. 2017 May 25;376(21):2097. [Dosage error in article text].

15.

International consensus guidance for management of myasthenia gravis: Executive summary.

Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P.

Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29. Review.

16.

What's in the Literature?

Silvestri NJ, Wolfe GI, Bromberg M, Lacomis D.

J Clin Neuromuscul Dis. 2016 Jun;17(4):227-38. doi: 10.1097/CND.0000000000000134.

PMID:
27224441
17.

Comment: Salbutamol--A means to an endplate.

Wolfe GI, Silvestri NJ.

Neurology. 2016 Feb 16;86(7):693. doi: 10.1212/WNL.0000000000002385. Epub 2016 Jan 20. No abstract available.

PMID:
26791151
18.

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.

Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM Jr, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM Jr, Hehir MK, Hobson-Webb LD, Howard JF Jr, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI.

Muscle Nerve. 2016 Feb;53(2):165-8. doi: 10.1002/mus.25009. Epub 2015 Dec 21. No abstract available.

PMID:
26662952
19.

Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.

Benatar M, Mcdermott MP, Sanders DB, Wolfe GI, Barohn RJ, Nowak RJ, Hehir M, Juel V, Katzberg H, Tawil R; Muscle Study Group (MSG).

Muscle Nerve. 2016 Mar;53(3):363-9. doi: 10.1002/mus.24769. Epub 2016 Jan 27.

20.

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.

Burns TM, Sanders DB, Kaminski HJ, Wolfe GI, Narayanaswami P, Venitz J.

Muscle Nerve. 2015 May;51(5):635-7. doi: 10.1002/mus.24608. Epub 2015 Mar 31. No abstract available.

PMID:
25704880
21.

Cerebral paragonimiasis: an unusual manifestation of a rare parasitic infection.

Kohli S, Farooq O, Jani RB, Wolfe GI.

Pediatr Neurol. 2015 Mar;52(3):366-9. doi: 10.1016/j.pediatrneurol.2014.11.001. Epub 2014 Nov 10.

PMID:
25556153
22.

Posterior reversible encephalopathy syndrome secondary to blood transfusion.

Singh K, Gupta R, Kamal H, Silvestri NJ, Wolfe GI.

J Clin Neurosci. 2015 Mar;22(3):592-4. doi: 10.1016/j.jocn.2014.10.005. Epub 2014 Dec 23.

PMID:
25542590
23.

Alfred Jaretzki III, MD.

Wolfe GI, Rowland LP.

Muscle Nerve. 2014 Sep;50(3):311-2. doi: 10.1002/mus.24334. Epub 2014 Aug 5. No abstract available.

PMID:
25042516
24.

Treatment-refractory myasthenia gravis.

Silvestri NJ, Wolfe GI.

J Clin Neuromuscul Dis. 2014 Jun;15(4):167-78. doi: 10.1097/CND.0000000000000034. Review.

PMID:
24872217
25.

Treatment of painful peripheral neuropathy.

Trivedi JR, Silvestri NJ, Wolfe GI.

Neurol Clin. 2013 May;31(2):377-403. doi: 10.1016/j.ncl.2013.01.003. Epub 2013 Mar 6. Review.

PMID:
23642715
26.

Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia).

Silvestri NJ, Wolfe GI.

Muscle Nerve. 2013 Jun;47(6):805-15. doi: 10.1002/mus.23755. Epub 2013 Apr 29. Review.

PMID:
23625835
27.

North America and South America (NA-SA) neuropathy project.

Pasnoor M, Nascimento OJ, Trivedi J, Wolfe GI, Nations S, Herbelin L, de Freitas MG, Quintanilha G, Khan S, Dimachkie M, Barohn R.

Int J Neurosci. 2013 Aug;123(8):563-7. doi: 10.3109/00207454.2013.782026. Epub 2013 Apr 17.

PMID:
23461611
28.

Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample.

Haley RW, Charuvastra E, Shell WE, Buhner DM, Marshall WW, Biggs MM, Hopkins SC, Wolfe GI, Vernino S.

JAMA Neurol. 2013 Feb;70(2):191-200. doi: 10.1001/jamaneurol.2013.596.

PMID:
23407784
29.

Introduction for Myasthenia Gravis and Related Disorders.

Wolfe GI, Meriggioli MN, Ciafaloni E, Ruff RL.

Ann N Y Acad Sci. 2012 Dec;1275:vii-viii. doi: 10.1111/nyas.12013. No abstract available. Erratum in: Ann N Y Acad Sci. 2013 Jan;1277:159.

PMID:
23278589
30.

Biomarker development for myasthenia gravis.

Kaminski HJ, Kusner LL, Wolfe GI, Aban I, Minisman G, Conwit R, Cutter G.

Ann N Y Acad Sci. 2012 Dec;1275:101-6. doi: 10.1111/j.1749-6632.2012.06787.x. Review.

31.

Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.

Benatar M, Sanders DB, Wolfe GI, McDermott MP, Tawil R.

Ann N Y Acad Sci. 2012 Dec;1275:17-22. doi: 10.1111/j.1749-6632.2012.06780.x.

PMID:
23278573
32.

Introduction for myasthenia gravis and related disorders.

Wolfe GI, Meriggioli MN, Ciafaloni E, Ruff RL.

Ann N Y Acad Sci. 2012 Dec;1274:vii-viii. doi: 10.1111/j.1749-6632.2012.06835.x. No abstract available. Erratum in: Ann N Y Acad Sci. 2013 Jan;1277:159.

PMID:
23252910
33.

Myasthenia gravis.

Silvestri NJ, Wolfe GI.

Semin Neurol. 2012 Jul;32(3):215-26. doi: 10.1055/s-0032-1329200. Epub 2012 Nov 1. Review.

PMID:
23117946
34.

Recommendations for myasthenia gravis clinical trials.

Benatar M, Sanders DB, Burns TM, Cutter GR, Guptill JT, Baggi F, Kaminski HJ, Mantegazza R, Meriggioli MN, Quan J, Wolfe GI; Task Force on MG Study Design of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

Muscle Nerve. 2012 Jun;45(6):909-17. doi: 10.1002/mus.23330.

PMID:
22581550
35.

Idiopathic neuropathy: new paradigms, new promise.

Singer MA, Vernino SA, Wolfe GI.

J Peripher Nerv Syst. 2012 May;17 Suppl 2:43-9. doi: 10.1111/j.1529-8027.2012.00395.x. Review.

PMID:
22548623
36.

Consensus treatment recommendations for late-onset Pompe disease.

Cupler EJ, Berger KI, Leshner RT, Wolfe GI, Han JJ, Barohn RJ, Kissel JT; AANEM Consensus Committee on Late-onset Pompe Disease.

Muscle Nerve. 2012 Mar;45(3):319-33. doi: 10.1002/mus.22329. Epub 2011 Dec 15. Review.

37.

Implementing clinical trials on an international platform: challenges and perspectives.

Minisman G, Bhanushali M, Conwit R, Wolfe GI, Aban I, Kaminski HJ, Cutter G.

J Neurol Sci. 2012 Feb 15;313(1-2):1-6. doi: 10.1016/j.jns.2011.10.004. Epub 2011 Nov 1. Review.

38.

MG-ADL: still a relevant outcome measure.

Muppidi S, Wolfe GI, Conaway M, Burns TM; MG COMPOSITE AND MG-QOL15 STUDY GROUP.

Muscle Nerve. 2011 Nov;44(5):727-31. doi: 10.1002/mus.22140.

PMID:
22006686
39.

Cytokines in Guillain-Barré syndrome: a lesson in time.

Lambracht-Washington D, Wolfe GI.

Arch Neurol. 2011 Apr;68(4):427-8. doi: 10.1001/archneurol.2011.47. No abstract available.

PMID:
21482922
40.

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis.

Burns TM, Grouse CK, Wolfe GI, Conaway MR, Sanders DB; MG Composite and MG-OL15 Study Group.

Muscle Nerve. 2011 Jan;43(1):14-8. doi: 10.1002/mus.21883.

PMID:
21082698
41.

Isolated neck extensor myopathy: is it responsive to immunotherapy?

Muppidi S, Saperstein DS, Shaibani A, Nations SP, Vernino S, Wolfe GI.

J Clin Neuromuscul Dis. 2010 Sep;12(1):26-9. doi: 10.1097/CND.0b013e3181d4a515.

PMID:
20808161
42.

Therapy update in nerve, neuromuscular junction and myopathic disorders.

Sadeghian H, Wolfe GI.

Curr Opin Neurol. 2010 Oct;23(5):496-501. doi: 10.1097/WCO.0b013e32833d7367. Review.

PMID:
20664347
43.

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.

Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L, McVey A, Dimachkie M, Kissel J, Walsh R, Amato A, Mozaffar T, Hungs M, Chui L, Goldstein J, Novella S, Burns T, Phillips L, Claussen G, Young A, Bertorini T, Oh S.

Muscle Nerve. 2010 Mar;41(3):370-4. doi: 10.1002/mus.21533.

PMID:
19882635
44.

Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.

Muppidi S, Wolfe GI.

Front Neurol Neurosci. 2009;26:109-19. doi: 10.1159/000212372. Epub 2009 Apr 6. Review.

PMID:
19349708
45.

Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches.

Meyer DM, Herbert MA, Sobhani NC, Tavakolian P, Duncan A, Bruns M, Korngut K, Williams J, Prince SL, Huber L, Wolfe GI, Mack MJ.

Ann Thorac Surg. 2009 Feb;87(2):385-90; discussion 390-1. doi: 10.1016/j.athoracsur.2008.11.040.

PMID:
19161744
46.

Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis.

Wolfe GI, Barohn RJ, Sanders DB, McDermott MP.

Muscle Nerve. 2008 Nov;38(5):1429-1433. doi: 10.1002/mus.21142.

PMID:
18949779
47.

The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.

Aban IB, Wolfe GI, Cutter GR, Kaminski HJ, Jaretzki A 3rd, Minisman G, Conwit R, Newsom-Davis J; Mgtx Advisory Committee.

J Neuroimmunol. 2008 Sep 15;201-202:80-4. doi: 10.1016/j.jneuroim.2008.05.031. Erratum in: J Neuroimmunol. 2009 Dec 10;217(1-2):103.

48.

Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.

Newsom-Davis J, Cutter G, Wolfe GI, Kaminski HJ, Jaretzki A 3rd, Minisman G, Aban I, Conwit R.

Ann N Y Acad Sci. 2008;1132:344-7. doi: 10.1196/annals.1405.014.

PMID:
18567886
49.

Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.

Wolfe GI, Oh SJ.

Ann N Y Acad Sci. 2008;1132:71-5. doi: 10.1196/annals.1405.005.

PMID:
18567855
50.

Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.

Nations SP, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI, Hynan LS, Reisch J, Trivedi JR.

Neurology. 2008 Aug 26;71(9):639-43. doi: 10.1212/01.wnl.0000312375.79881.94. Epub 2008 Jun 4.

PMID:
18525032

Supplemental Content

Loading ...
Support Center